Quantum stocks faced a downturn during afternoon trading, with IonQ standing out as an outlier. Read more here.
A subsidiary of a Miami-based company is inching closer to FDA approval for a drug that treats a rare pediatric disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback